Form D · Biotechnology

Enumeral Biomedical Corp.

New York, NY · CIK 0001518957

Offering snapshot reported May 7, 2014 · SEC filing

Reported sold
$2.02M
Indefinite offering
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 25, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 7, 2014Initial$2,016,250No comparison5SEC filing
Feb 10, 2014Initial$635,000No comparison6SEC filing
May 14, 2013Initial$1,520,004No comparison10SEC filing
Jul 9, 2012Initial$2,272,973No comparison17SEC filing
Apr 29, 2011Initial$1,997,477No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$81.3K
Finders' fees
$0
Form D file number
021-216918
$81,300 in sales commission and warrants with a term of 5 years for approximately 38,258 Series B shares with an exercise price of $2.125

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
BlackBook Capital LLC123234

Source: Form D, filed May 7, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Derek Brand Executive
Barry Buckland Director
Emanuele Ostuni Director
Allan Rothstein Director
John Rydzewski Director, Executive
Arthur H. Tinkelenberg Director, Executive
Michael Weiss Director
Daniel Wolfe Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1450 Broadway, 24 Th Floor
New York, NY, 10018